Investigational Recombiant Protein Antiviral Testing

Other Immunotherapy and Immunotherapeutics testing, analysis, scientific research and development, inspection, certification, engineering, failure investigation, and product development needs include :

Clinical Trials: Phases I to IV to assess safety efficacy and dosing of immunotherapeutics Testing
Immunogenicity Testing: Evaluates whether a therapeutic triggers an immune response against itself potentially reducing its effectiveness Testing
Cell Viability and Proliferation Assays: Tests the ability of immune cells to survive and multiply in response to therapeutics Testing
Cytotoxicity Tests: Measures the ability of immune cells to kill cancer or infected cells after treatment Testing
Biomarker Testing: Identifies specific molecules that indicate the effects of the therapy on the immune system Testing

Learn more about immunotherapy and immunotherapeutics testing and research